4 completed, 2 recruiting, 1 not yet recruiting, 1 unknown. 9 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9 | Completed 4, Recruiting 2, Not yet recruiting 1, Unknown 1, Withdrawn 1 |
| Phase 2 | 4 | Completed 2, Not yet recruiting 1, Withdrawn 1 |
Follow Diabetes, Gestational: new trials by email Literature Review of Diabetes, Gestational trials Research Report on Diabetes, Gestational
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Islet Function in Gestational Diabetes Exendin 9-39 - Gestational Diabetes Mellitus | Phase 1 | Recruiting | Mayo Clinic | 90 | 2026-09-01 | 2026-09-08 |
| The Impact of Gestational Diabetes Mellitus on Cerebral Blood Flow and Cerebrovascular Function After Pregnancy Intradermal Microdialysis, Brain Blood Flow Tests, Local Heating - Gestational Diabetes Mellitus (GDM), Postpartum Women | Phase 1 | Recruiting | Anna Stanhewicz, PhD | 84 | 2025-08-22 | 2025-12-16 |
| Impact of Chromium Supplementation on Glucido-lipidic Metabolism, Oxidative Stress and Inflammatory State in Patients with Gestational Diabetes Oral chromium supplementation during gestational diabetes mellitus through the administration of chromium picolinate tablets (200 µg/d), Dietary Supplement: Oral chromium supplementation during gestational diabetes mellitus through the administration of chromium picolinate tablets (400 µg/d) - Gestational Diabetes Mellitus (GDM), Oxidative Stress | Phase 1 / Phase 2 | Not yet recruiting | University of Kasdi Merbah | 200 | 2025-05-01 | 2025-03-05 |
| PED NEONAT 20-000599 Fetal Body Composition 3T "Free-Breathing" Fetal Magnetic Resonance Imaging - IUGR, Gestational Diabetes | Phase 1 | Completed | University of California, Los Angeles | 23 | 2020-08-17 | 2023-08-30 |
| High Dose Cholecalciferol to Reduce the Incidence of Gestational Diabetes in High Risk Pregnant Women 4000 IU vitamin D3 - Gestational Diabetes | Phase 1 / Phase 2 | Withdrawn | University of Minnesota | 2017-06-01 | 2019-11-01 | |
| Mobile Health App to Reduce Diabetes in Latina Women Mobile health app called "Hola Bebe" - Gestational Diabetes | Phase 1 | Completed | Environment and Health Group, Inc. | 18 | 2014-07-22 | 2019-11-04 |
| Glyburide and Metformin for Gestational Diabetes Mellitus (GDM) Glyburide, Metformin, Glyburide-Metformin combination - Gestational Diabetes Mellitus | Phase 1 / Phase 2 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 177 | 2011-07-01 | 2026-05-11 |
| DHA Supplements to Improve Insulin Sensitivity in Obese Pregnant Women (The Omega-3 Pregnancy Study) DHA Supplements, Placebo Supplements - Overweight and Obesity, Insulin Resistance | Phase 1 | Unknown | National Heart, Lung, and Blood Institute (NHLBI) | 90 | 2009-04-01 | 2009-07-15 |
| Correlation of Continuous Glucose Monitoring and Glucose Tolerance Testing With Pregnancy Outcomes The Seven Continuous Glucose Monitoring System - Diabetes, Gestational | Phase 1 / Phase 2 | Completed | Stanford University | 57 | 2009-02-01 | 2016-05-19 |
Insulin Resistance (2) · Glucose Metabolism Disorders (1) · Hypertension, Pregnancy-Induced (1) · Lipid Metabolism Disorders (1) · Obesity (1) · Overweight (1) · Pre-Eclampsia (1)
Diabetes Mellitus (9) · Endocrine System Diseases (9) · Female Urogenital Diseases and Pregnancy Complications (9) · Metabolic Diseases (9) · Nutritional and Metabolic Diseases (9) · Pregnancy Complications (9) · Urogenital Diseases (9) · Glucose Metabolism Disorders (8) · Hyperinsulinism (2) · Body Weight (1) · Cardiovascular Diseases (1) · Hypertension (1) · Nutrition Disorders (1) · Overnutrition (1) · Pathological Conditions, Signs and Symptoms (1)
Cholecalciferol (1) · Glyburide (1) · Metformin (1) · exendin (9-39) (1)
Anna Stanhewicz, PhD (1) · Environment and Health Group, Inc. (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Mayo Clinic (1) · National Heart, Lung, and Blood Institute (NHLBI) (1) · Stanford University (1) · University of California, Los Angeles (1) · University of Kasdi Merbah (1) · University of Minnesota (1)
United States (8) · Algeria (1)
Aoife Egan, MB, BCh, PhD (1) · David Flockhart, MD, PhD (1) · Debra A. Krummel, PhD, RD (1) · Gary DV Hankins, MD (1) · Mary F. Hebert, PharmD, FCCP (1) · Samantha Hoffman, MD (1) · Steve Caritis, MD (1) · Yasser Yehia El-Sayed (1)
PMID 25262455, PMID 29053802, PMID 31742716, PMID 31869430, PMID 31980499, PMID 33382039
R01DK148528 (1), R44MD009454 (1)